Dr. Elmer Tu, MD

Claim this profile

University of Illinois, Chicago

Studies Eye Infection
Studies Corneal Infection
2 reported clinical trials
3 drugs studied

Affiliated Hospitals

Image of trial facility.
University Of Illinois Chicago
Image of trial facility.
University Of Illinois

Clinical Trials Elmer Tu, MD is currently running

More about Elmer Tu, MD

Clinical Trial Related7 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Elmer Tu, MD has experience with
  • Topical Corticosteroid
  • Masked Placebo
  • Valacyclovir

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elmer Tu, MD specialize in?
Elmer Tu, MD focuses on Eye Infection and Corneal Infection. In particular, much of their work with Eye Infection has involved treating patients, or patients who are undergoing treatment.
Is Elmer Tu, MD currently recruiting for clinical trials?
Yes, Elmer Tu, MD is currently recruiting for 1 clinical trial in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Elmer Tu, MD has studied deeply?
Yes, Elmer Tu, MD has studied treatments such as Topical corticosteroid, Masked Placebo, Valacyclovir.
What is the best way to schedule an appointment with Elmer Tu, MD?
Apply for one of the trials that Elmer Tu, MD is conducting.
What is the office address of Elmer Tu, MD?
The office of Elmer Tu, MD is located at: University of Illinois, Chicago, Chicago, Illinois 60612 United States. This is the address for their practice at the University of Illinois, Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.